VCYT (STOCKS)
Veracyte, Inc.
$42.670000
-2.010000 (-4.50%)
Prev close: $44.680000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Marc A. Stapley
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,424.64M
- Employees
- 824
- P/E (TTM)
- 31.70
- P/B (TTM)
- 2.59
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
8
Buy
2
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$0.31 | $0.24 | +0.0681 | +28.15% |
|
Mar 2026 (Q1)
|
$0.35 | $0.15 | +0.1999 | +133.18% |
|
Dec 2025 (Q4)
|
$0.51 | $0.22 | +0.2907 | +132.56% |
|
Sep 2025 (Q3)
|
$0.24 | $0.13 | +0.1059 | +78.97% |
Financial Statements
| Revenues | $561.90M |
| Benefits Costs and Expenses | $445.88M |
| Cost Of Revenue | $158.94M |
| Costs And Expenses | $297.20M |
| Gross Profit | $402.96M |
| Operating Expenses | $297.20M |
| Research and Development | $93.37M |
| Other Operating Expenses | $203.83M |
| Operating Income/Loss | $105.77M |
| Income/Loss From Continuing Operations After Tax | $114.48M |
| Income/Loss From Continuing Operations Before Tax | $116.02M |
| Income Tax Expense/Benefit | $1.54M |
| Net Income/Loss | $114.48M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $114.48M |
| Net Income/Loss Available To Common Stockholders, Basic | $114.48M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $1.44 |
| Diluted Earnings Per Share | $1.40 |
| Basic Average Shares | 238,434,236 |
| Diluted Average Shares | 243,691,487 |
| Assets | $1.49B |
| Current Assets | $574.78M |
| Noncurrent Assets | $911.59M |
| Intangible Assets | $82.70M |
| Other Non-current Assets | $828.89M |
| Liabilities | $97.96M |
| Current Liabilities | $62.74M |
| Accounts Payable | $8.02M |
| Wages | $25.13M |
| Other Current Liabilities | $29.58M |
| Noncurrent Liabilities | $35.23M |
| Equity | $1.39B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $1.39B |
| Liabilities And Equity | $1.49B |
| Net Cash Flow From Operating Activities | $178.38M |
| Net Cash Flow From Operating Activities, Continuing | $178.38M |
| Net Cash Flow From Investing Activities | -$98.67M |
| Net Cash Flow From Investing Activities, Continuing | -$98.67M |
| Net Cash Flow From Financing Activities | $338.00K |
| Net Cash Flow From Financing Activities, Continuing | $338.00K |
| Exchange Gains/Losses | -$12.00K |
| Net Cash Flow | $80.03M |
| Net Cash Flow, Continuing | $80.05M |
| Comprehensive Income/Loss | $118.50M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $118.50M |
| Other Comprehensive Income/Loss | $118.50M |